REP1 Gene Replacement Therapy for Choroideremia
NCT02407678
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
30
Enrollment
OTHER
Sponsor class
Conditions
Choroideremia
Interventions
GENETIC:
AAV-mediated REP1 gene replacement
Sponsor
University of Oxford
Collaborators
[object Object]
[object Object]